Boston Scientific to acquire Baylis Medical Company for US $ 1.75 billion
The transaction is anticipated to close in the first quarter of 2022
The transaction is anticipated to close in the first quarter of 2022
The NanoDrop Eight simultaneously evaluates eight samples in 20 seconds or less and the instrument can also measure high-concentration samples of up to 200 absorbance units without dilution
It approves tissue-based NGS companion diagnostic for Takeda's targeted therapy for NSCLC patients with EGFR Exon20 insertion mutations
High-resolution image-based ART workflow software uses artificial intelligence to provide objective embryo grading, to assist embryologists during embryo selection
Formulation business grew by 15 per cent in the quarter
The company has already embarked upon significant expansion in Turkey
AI-powered cardiometabolic wellness platform for India’s workforce
New AI capabilities will help scientists identify, optimize, and validate new molecules. Additional applications include manufacturing, medical imaging, and enterprise AI agents
Results demonstrate favorable safety profile and clinically meaningful improvements in patients with non-ischemic heart failure
 
        Subscribe To Our Newsletter & Stay Updated